← Open Payments lookup

JEREMY STAATS: Open Payments

NPI 1407596257 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$743 in 41 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $795 · 2025 $743

Food & beverage: $743
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.9$168
Janssen Pharmaceuticals, Inc6$117
Otsuka America Pharmaceutical, Inc.4$81
E.R. Squibb & Sons, L.L.C.4$73
Teva Pharmaceuticals USA, Inc.4$63
ABBVIE INC.4$60
Vanda Pharmaceuticals Inc.3$56
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$36
Alkermes, Inc.2$35
Axsome Therapeutics, Inc.1$19

Products named: INGREZZA, INVEGA, COBENFY, AUSTEDO XR, REXULTI, VRAYLAR, FANAPT, ABILIFY ASIMTUFII.

Industry payments across NJ — which companies pay providers there.